Essay PreviewMore ↓
In recent years, the price of research and development has skyrocketed, making it very difficult and expensive to introduce new drugs into the market. Companies are spending more than ever from their profit of sales revenues into research and development. Now looking at it from this point of view, a newly merged company will have such high profit and revenue that they will have the opportunity to spend as much as they want on research and development, without money being an issue or a concern. Technology is improving by the day, and with the merging of companies-these companies will join technologies and join their research making their progress advance exponentially. Our company- Verduga Inc.-has wasted a lot of money recently on research and development. If we were to merge with Coronado-Salinas Inc., we would see a vast increase in the amount of capital available to us to use in research and development. The downside is that research and development sometimes turns out to be just research. Big companies can get overconfident and after getting a couple of results they might get too compulsive and overspend in research and development.
How to Cite this Page
"Mega-Mergers In The Pharmaceutical Industry." 123HelpMe.com. 04 Apr 2020
Need Writing Help?
Get feedback on grammar, clarity, concision and logic instantly.Check your paper »
- ... Large pharmaceutical firms have semi-annual reorganization in corporate design using new organization formats of matrix management, centers of excellence; end-to-end therapeutic area groups vs functional lines, disease area strategies rather than site strategies, etc. These cause constant organizational upheaval and impact productivity • High adaptation costs for clinical trial: Currently, many pharmaceutical and biotech companies consider entering the Chinese market through clinical trials.... [tags: culture, economy, standards]
975 words (2.8 pages)
- Large pharmaceutical industries are making big profits on medications because they charge high prices for profit. These pharmaceutical companies are overcharging for medications that are essential to maintaining the health of patients. Having such a high cost for medication prevents patients from receiving the care that they need. This may result in patients resorting to desperate measure such as stealing and other illegal acts. The pharmaceutical industry need to reevaluate their ethical standards because the way that these companies are going about pricing their drugs is preventing patients from living a health life.... [tags: Pharmacology, Pharmacy, Pharmaceutical industry]
802 words (2.3 pages)
- Large pharmaceutical industries are making large profits on medications. Having such a high cost for medication prevents patients from receiving the care that they need. These companies are overcharging for medications that are essential to maintaining the health of patients. This may result in patients resorting to desperate measure such as stealing, crime, and other illegal acts. The pharmaceutical industry may require a different set of moral standard because in a way these laws are preventing patients from a quality life.... [tags: Pharmaceutical industry, Pharmacology, Pharmacy]
1598 words (4.6 pages)
- The market players, which in this case are leading pharmaceutical companies, would normally buy supplies, such as active pharmaceutical ingredients (APIs), from major suppliers that form sub-sector of the chemical industry. These are provided on a contractual basis and most pharmaceutical companies face high switching costs if they decide to change suppliers. That is why a number of these companies decided to invest in chemical manufacturing and become partially self- sufficient. Another way in which these market players are able to reduce the supplier power is through purchasing their raw materials from multiple suppliers; since their laboratory equipment and chemical ingredients show littl... [tags: Pharmacology, Pharmaceutical industry]
1199 words (3.4 pages)
- What is the justification for such dramatic increases in cost. The first method utilized to explore this question was to verify the relationship of cost with research and development. This was done by examining scientific research linking increases in expense to increases in drug costs. Next, the impacts of patents, length of time needed for Food and Drug Administration (FDA) approval, and limits to cost minimization by state laws and federal policies were investigated by reviewing economic journal articles on these topics.... [tags: Pharmacology, Pharmaceutical industry]
1286 words (3.7 pages)
- Introduction: Merck had a reputation of providing the best research in order to find the cure for diseases such as AIDS, tuberculosis, hypertension. They spend on average around $3 billion dollars on research on a yearly basis. However, they needed to produce a drug that would take Merck to the next level. Merck created Vioxx which was designed to treat osteoarthritis and in May 1999, the FDA approved Vioxx making it available with a medical prescription (Snigdha., 2007). During this period they were plenty of changes in the pharmaceutical industry.... [tags: Pharmacology, Pharmaceutical industry, Shareholder]
2243 words (6.4 pages)
- Study on Technology Industry’s Mergers Jianyun Wang 1.Introduction Dell has announced to buy data storage giant technology company EMC by paying $67 billion in Oct 12th 2015, which is the largest merger deal in the technology industry in recent years. This two giant technology companies’ combination not only gives a big shock to the whole industry, but also leads the merger wave in the technology industry to a new peak. Merger has been one of the most popular and direct strategies for most of the company to develop their business, especially in the technology industry.... [tags: Mergers and acquisitions, Marketing, Technology]
1316 words (3.8 pages)
- Introduction This paper will focus on the technological developments that are driving the pharmaceutical industry. Governmental oversight imposed by the Food and Drug Administration requires strict accountability and quality control. We will look to the fast food industry for best practices considering the FDA also regulates this industry as well. A repeatable and auditable system of production, operation, and distribution will be the cornerstones of the technology employed. Pharmaceutical Industry The pharmaceutical industry is a highly regulated industry that is subject to continuous audits and monitoring form the government.... [tags: Pharmaceutical Industry Technology Innovation]
1751 words (5 pages)
- Mergers and Acquisitions Companies merge and acquire other companies for various strategic reasons with various degrees of success. The success of a merger is measured by whether the value of the acquiring firm is enhanced by it. The practical aspects of mergers often prevent the forecasted benefits from being fully realized and the expected synergy may fall short of expectations. This paper discusses three examples of recent mergers, the forces that drive companies to buy or merge with others, and the financial outcomes of each case.... [tags: Business Mergers]
984 words (2.8 pages)
- Mega-mergers is a combination of two are more major companies joining together according to Eitzen (365) in 2006 Mergers and acquisitions in the united states alone were worth 1.45 trillion. There are thousands of mergers each year that makes giant corporation become more bigger. For example Time, Inc., and AOL joining with Warner Communications, Texaco buying out Getty Oil, and other mergers that combined with foreign firms like British Petroleum with Amoco and Daimler with Chrysler. There are nsix negative consequences of mega mergers are: (1) It increases the centralization of capital, which causes a reduction competition also raises prices for consumers; (2) It increases the power of hu... [tags: Business, Foreign Firms, Corporations, Capitalism]
750 words (2.1 pages)
Research scientists like to specialize in their work and conduct experiments and research individually. So when mega-mergers are in progress, the scientists feel like they are not as much of a part of their research as they would be in a smaller company. In comparison, it is almost like a school, where the different departments are always itching for a bigger part of the budget. Research scientists do not want to be part of the same problem and therefore find bigger companies unappealing.
When two companies merge some of their offices get shut down. Some get transferred to different departments in different cities, but most end up becoming unemployed. Verduga Inc. Has offices in six different cities. We are a very big company and to excel in our customer satisfaction and product quality we maintain high standards in our obligations to our employees. This means that there is a great possibility that when we merge we will risk losing the smaller, but in no means less important, offices. Since we value our employees as much as our customers we consider this to be a heavy loss and a great disadvantage to the possibility of merging with a greater company. This will augment unemployment in those cities and greatly affect their local economies as well. However, with the merging of our companies we will also gain valuable assets and new employees from the other company. This will expose us to fresh, and more innovative ideas that can ultimately lead in more progress and profit for our company.
Different companies also have varying ways of managing their companies. Some companies may prefer to centralize their decision-making as opposed to others that may decide to give more autonomy to their regional companies. Also, the company that we are interested in merging with is based in Western Europe. We are hoping that their radically different approach to problem-solving and management can lead to different perspectives and hopefully, new better ideas that can increase out profit and help us accomplish our goals. However, at the same time, the same reason that we are hoping will lead us to success can also be the cause of a culture-clash and descent within the company. It is unpredictable whether the changes and differences in structure and decision making will either help in the progress of this company, or rather hinder its path to success.
The pharmaceutical industry is a profit-based industry, and as such we must seek to meet the demands of our shareholders. We must seek to maximize profit and increase the number of stocks exponentially. Ever since rumors and speculation started about the possibilities of a merge between Coronado-Salinas Inc. and us the value of our stocks has skyrocketed. Meeting the demands of our shareholders has always been a challenge that we strive to meet. However, now that the rumors have been spread, their demands and expectations for our future will be a much greater, and our actions to meet them will be more of a struggle than it ever has been. However, with the merging of the two companies our capacity to meet those demands will be much higher than it ever has been. Were we to merge we would have an increased amount of shareholders and income and with our increased manpower, we have a broader range of possibilities and more ways than ever to make profit for our shareholders. We are not the only ones that can possibly benefit from this merge. Our business partners can also profit and see an increase in the value of their stocks as well because there is a chance that we may also merge with them in the future. And at the same time, they will also benefit from our joint increase in newfound creativity.
With the merging of these two companies, we believe that an influx of new ideas will lead to an increased spectrum of innovation for us. We will be working hand in hand with a company that was trying to out compete us. But if the merger goes through then they can help us improve our existing products and we can do the same for them, either way it will ultimately result in the progress of the merged company. Furthermore, if the merge happens then we will be combining with one of our greatest competitors and in turn, it will not only decrease our competition but also simultaneously increase the profit to be had. Now, instead of focusing on outdoing our competition, our focus will be more fixed on satisfying and exceeding customer needs and demands. At the same time, Coronado-Salinas Inc. will also have one less competitor and in turn can shift its attention towards coming with more innovative ideas for higher quality products. However, the same aspects that can lead to our success and innovation can at the same time hinder the industry. Less competition in the pharmaceutical industry can also lead to less innovation. Companies will also feel less pressured to compete and not have the same drive to come up with new ideas to outdo other companies. Because when there is more competition, the drive to survive from other companies, drive the industry to come up with new ways to outdo each other, and this in turn brings new innovations every time. The difficulty of entering the pharmaceutical industry makes mergers such as these also dangerous because it creates virtual monopolies. The cost of entering the industry is in the millions, so existing companies can have a reasonably based sense of security. They can feel safe that new companies are unlikely to emerge.
All things being considered, we feel it would be in the best interests of our company to complete the merge. The benefits definitely outweigh the risks. Though some of the risks may, in the long run, end up hurting the pharmaceutical industry and, to a lesser extent, maybe even end up hurting us, we feel as though we have the means and the will to overcome any possible adversity that we may be faced with. The flood of money and new ideas that would inundate our company will lead to increased profit and customer satisfaction and ensure our success for many years to come.
Gershon, Diane. "Are mega-mergers good medicine for the pharmaceutical industry?". Nature. 09 Mar 2008 .
Lundvall, Karl. "The Pros and Cons of Merger Control". Social Science Research Network. 09 Mar 2008 .
Subramanyan , S. . "ILO study on M&As -- The pros and cons of mergers ". Business Line. 09 Mar 2008 .